Not approved (research only)Short bioregulator peptideVascular research
Vesugen
Vesugen is a short synthetic peptide from the bioregulator research tradition with limited published data.
What is Vesugen?
Vesugen is a short synthetic peptide from the bioregulator research tradition with limited published data. Vesugen is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Key takeaways
- Vesugen is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
- PubMed indexes 6 papers on Vesugen (0 tagged as clinical trials) as of October 19, 2026.
- 11 vendors in our directory listed Vesugen in their public catalog on October 19, 2026.
Regulatory & access status
Vesugen is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Sellers that market unapproved peptides for human use can receive FDA warning letters; our vendor directory links any letter we found on fda.gov.
How much research exists on Vesugen?
PubMed indexes 6 papers mentioning Vesugen in the title or abstract, 0 of them from the last five years and 0 tagged as clinical trials (search run October 19, 2026; repeat the search).
Most relevant recent papers
- [EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION]. — Adv Gerontol, 2015
- [Epigenetic aspects of peptidergic regulation of vascular endothelial cell proliferation during aging]. — Adv Gerontol, 2014
- [Investigation of antihypoxic properties of short peptides]. — Adv Gerontol, 2008
- Peptides tissue-specifically stimulate cell differentiation during their aging. — Bull Exp Biol Med, 2012
- Peptidegic stimulation of differentiation of pineal immune cells. — Bull Exp Biol Med, 2011
- [Biological activity of regulatory peptides in model experiments in vitro]. — Adv Gerontol, 2008
What the evidence does not show
- Paper counts measure research attention, not whether Vesugen works or is safe.
- No clinical trial in humans is tagged in PubMed under this name.
- No FDA review of any "research use only" product's identity, purity, sterility or dose.
Research suppliers that list Vesugen
11 vendors in our directory listed a product matching Vesugen in their public catalog on October 19, 2026. Listed alphabetically; a listing is not an endorsement. Research use only.
- BioLongevity Labs
- Core Peptides
- Eros Peptides
- Liberty Peptides
- Modern Aminos
- NuScience Peptides
- ProtideHealth
- Pure Lab Peptides
- Royal Peptides
- Verified Peptides
- Xcel Peptides
Prices per mg, where we could verify them, are on our price comparison.
Vesugen reconstitution math
Lab arithmetic only, not dosing guidance: use the peptide calculator to turn a vial size and diluent volume into a concentration.
Vesugen FAQ
Is Vesugen FDA-approved?
Vesugen is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Is Vesugen safe?
There are no published human safety trials of Vesugen that we could find. Products sold as "research use only" have no FDA review of purity, sterility or dose, and are not for human use.
How much research is there on Vesugen?
PubMed indexes 6 papers on Vesugen (0 tagged as clinical trials) as of October 19, 2026.
Who sells Vesugen?
BioLongevity Labs, Core Peptides, Eros Peptides, Liberty Peptides, Modern Aminos, NuScience Peptides and 5 more listed it on their public catalogs when we checked; a listing is not an endorsement.
Related compounds
TRHMelanotan IPNC-27OvagenAOD-9604 + CJC-1295 + ipamorelin blendCardiogenLivagenCortagenAll bioregulators & other research compounds